The in vivo data confirm the systemic relevance of VSMC-EGFR during obesity with T2DM for vascular pathophysiology but they do not allow to answer the questions concerning a direct impact of T2DM/obesity-associated stress factors on VSMC or EC. The gene discussed is EGFR; the disease is type 2 diabetes mellitus.